UK Pharma Firm Wins US Backing For Antibody-Based COVID-19 Treatment
AstraZeneca has secured support from the US government to advance the development of antibody-based COVID-19 treatments as the British drugmaker ramps up efforts beyond...
UCB Acquires Engage Therapeutics for $125M
UCB announced the acquisition of Engage Therapeutics, Inc. (Summit, N.J. (U.S.)), a clinical-stage pharmaceutical company developing Staccato®Alprazolam for the rapid termination of an active...
Cellbox Solutions Appoints Dr. Herbert Mueller-Hartmann as Head of Research and Development
Cellbox Solutions GmbH announces the appointment of former Head of Biosolutions R&D from Lonza Pharma and Biotech, Dr. Herbert A. Mueller-Hartmann, as the new...
Lonza to Host New Webinar – “The Compendia are ready. Are you? A More Sustainable Future for Endotoxin Testing”
On 16 June, Lonza will host a free 60-minute webinar on the latest regulatory developments surrounding the use of the recombinant Factor C (rFC)...
Vetter wins Axia Best Managed Company Award
Vetter has been awarded the Axia Best Managed Companies Award for its outstanding corporate management. The coveted seal of approval is awarded once a...
FSD Pharma Gets Go Ahead for Phase IIa COVID-19 Trial
FSD Pharma Inc. received approval from the U.S. FDA to submit an Investigational New Drug Application (IND) for the use of FSD-201 (ultramicronized palmitoylethanolamide,...
AstraZeneca Forges RNA-Modifying Protein Oncology Deal with Accent Therapeutics
Accent Therapeutics and AstraZeneca forged a collaboration valued at about $1.1 billion to discover, develop and commercialize transformative therapeutics targeting RNA-modifying proteins (RMPs) for...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...